Entera Bio
Price & Volume
Stats
See more52W Range | $0.91-$3.22 |
Market Cap | $59.1M |
Shares Short | 177,670 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 3 days ago
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
Yahoo Finance • 4 days ago
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
Yahoo Finance • last month
Entera Bio GAAP EPS of -$0.07 beats by $0.02
Yahoo Finance • last month
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
About
CEO | Ms. Miranda J. Toledano M.B.A. |
Address | Kiryat Hadassah Minrav Building, Jerusalem, Israel, 9112002 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |